{
  "meta": {
    "title": "Mid_Day_Module_Medicine-9",
    "url": "https://brainandscalpel.vercel.app/mid-day-module-medicine-9-b8e52f3b.html",
    "scrapedAt": "2025-11-29T18:15:15.799Z"
  },
  "questions": [
    {
      "id": 92171,
      "choices": [
        {
          "id": 367000,
          "text": "<p><span style=\"font-size:14.0pt;\">Ceftriaxone</span></p>"
        },
        {
          "id": 367001,
          "text": "<p><span style=\"font-size:14.0pt;\">Tetracycline</span></p>"
        },
        {
          "id": 367002,
          "text": "<p><span style=\"font-size:14.0pt;\">Amoxicillin</span></p>"
        },
        {
          "id": 367003,
          "text": "<p><span style=\"font-size:14.0pt;\">Vancomycin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">What is the preferred treatment of penicillin-resistant Gram-negative diplococci (Neisseria meningitidis)? (INICET MAY 2025)&nbsp;</span></p>",
      "unique_key": "Q2092963",
      "question_audio": null,
      "question_video": null,
      "map_id": 35489174,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Ceftriaxone</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Ceftriaxone is the preferred treatment for penicillin-resistant Neisseria meningitidis. For penicillin-sensitive strains, intravenous penicillin G remains the treatment of choice.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">However, when dealing with penicillin-resistant strains or when empirical therapy for meningitis is needed, third-generation cephalosporins, particularly ceftriaxone, are considered the gold standard.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Ceftriaxone has excellent penetration into the cerebrospinal fluid and provides reliable coverage against both penicillin-sensitive and penicillin-resistant Neisseria meningitidis strains. It is also the preferred empirical therapy for bacterial meningitis in most clinical scenarios.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Tetracycline:</strong> This antibiotic does not have reliable activity against Neisseria meningitidis and is not recommended for treating meningococcal infections. It also has poor penetration into the central nervous system.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Amoxicillin:</strong> Like other penicillins, amoxicillin would be ineffective against penicillin-resistant strains of Neisseria meningitidis. It would only be appropriate for penicillin-sensitive strains, but even then, intravenous penicillin G would be preferred.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Vancomycin:</strong> This antibiotic is predominantly active against Gram-positive organisms and has no significant activity against Gram-negative bacteria like Neisseria meningitidis. It would be completely ineffective for treating meningococcal infections.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Ceftriaxone is the preferred treatment for penicillin-resistant Neisseria meningitidis and the gold standard for empirical bacterial meningitis therapy.</span></p>",
      "correct_choice_id": 367000,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92171/INI_CET_May_2025_Medicine_Q_-_27.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92171/INI_CET_May_2025_Medicine_Q_-_27.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74902,
      "choices": [
        {
          "id": 298505,
          "text": "<p><span style=\"font-size:16px;\">Smoking</span></p>"
        },
        {
          "id": 298506,
          "text": "<p><span style=\"font-size:16px;\">Standing posture</span></p>"
        },
        {
          "id": 298507,
          "text": "<p><span style=\"font-size:16px;\">Hyperglycemia</span></p>"
        },
        {
          "id": 298508,
          "text": "<p><span style=\"font-size:16px;\">Exercise</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Which of the following is not a stimulus for catecholamine synthesis? (INICET NOV 2024)</span></p>",
      "unique_key": "Q2963376",
      "question_audio": null,
      "question_video": null,
      "map_id": 35489175,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C) Hyperglycemia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Hyperglycemia is not a stimulus for catecholamine synthesis. Physiologically, hyperglycemia can suppress catecholamine synthesis. While hyperglycemic emergencies may indirectly lead to increased catecholamines due to shock and osmotic diuresis, hyperglycemia itself does not directly stimulate catecholamine production. Hypoglycemia (not hyperglycemia) is a potent stimulus for catecholamine release, leading to autonomic symptoms like tremors, palpitations, anxiety, and sweating.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Smoking:</strong> Incorrect. Smoking is a known stimulus for catecholamine synthesis. Nicotine triggers the release of catecholamines from the adrenal medulla and sympathetic nerve endings.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Standing posture:</strong> Incorrect. Orthostatic changes require a catecholamine surge to prevent orthostatic hypotension when a person stands up. This is a normal physiological response.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Exercise:</strong> Incorrect. Exercise is one of the major physiological stimuli for catecholamine synthesis. Physical activity requires increased sympathetic activation and catecholamine production.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Hypoglycemia (not hyperglycemia) is a potent stimulus for catecholamine release, leading to autonomic symptoms like tremors, palpitations, anxiety, and sweating. Hyperglycemia does not stimulate catecholamine synthesis.</span></p>",
      "correct_choice_id": 298507,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/74902/INI-CET_NOV_2024_Medicine_Q_-_27.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/74902/INI-CET_NOV_2024_Medicine_Q_-_27.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 92172,
      "choices": [
        {
          "id": 367004,
          "text": "<p><span style=\"font-size:14.0pt;\">Acetaminophen</span></p>"
        },
        {
          "id": 367005,
          "text": "<p><span style=\"font-size:14.0pt;\">Amoxicillin-clavulanate</span></p>"
        },
        {
          "id": 367006,
          "text": "<p><span style=\"font-size:14.0pt;\">Isoniazid</span></p>"
        },
        {
          "id": 367007,
          "text": "<p><span style=\"font-size:14.0pt;\">Estrogens/ Androgens</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following medications is most commonly associated with cholestasis in the absence of significant portal inflammation? (INICET MAY 2025)</span></p>",
      "unique_key": "Q4628770",
      "question_audio": null,
      "question_video": null,
      "map_id": 35489176,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Estrogens/Androgen</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Estrogens and androgens are known to cause bland cholestasis, which is characterized by cholestasis without portal inflammation. This type of drug-induced liver injury presents with elevated alkaline phosphatase and bilirubin but lacks the inflammatory component seen in other forms of drug-induced hepatotoxicity.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Other drugs that can cause bland cholestasis include certain SERMs (especially tamoxifen), cyclosporine, griseofulvin, and some sulfonylureas. The mechanism involves direct interference with bile flow without causing significant hepatocellular damage or inflammatory infiltrate.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Acetaminophen:</strong> This drug causes centrilobular necrosis, which is a form of hepatocellular injury rather than cholestasis. It produces direct hepatotoxicity through metabolite-induced cellular damage, not cholestatic injury.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Amoxicillin-clavulanate:</strong> This combination is known to cause cholestatic hepatitis, which includes both cholestasis AND portal inflammation. It is currently considered one of the most common causes of drug-induced cholestasis worldwide, particularly in Caucasian populations, but it causes inflammatory cholestasis rather than bland cholestasis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Isoniazid:</strong> This anti-tuberculosis drug typically causes hepatocellular injury rather than cholestasis. It can cause acute hepatitis with elevated transaminases but is not known for causing pure cholestatic injury without inflammation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Estrogens and androgens cause bland cholestasis (cholestasis without portal inflammation), while other drugs typically cause either hepatocellular injury or cholestatic hepatitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_JEqSlZx.png\" width=\"935\" height=\"260\"></span></p>",
      "correct_choice_id": 367007,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92172/Ini_Cet_May_2025_Medicine_Q_-_28new.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92172/Ini_Cet_May_2025_Medicine_Q_-_28new.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74903,
      "choices": [
        {
          "id": 298509,
          "text": "<p><span style=\"font-size:16px;\">1-C, 2-B, 3-D, 4-A</span></p>"
        },
        {
          "id": 298510,
          "text": "<p><span style=\"font-size:16px;\">1-D, 2-A, 3-C, 4-B</span></p>"
        },
        {
          "id": 298511,
          "text": "<p><span style=\"font-size:16px;\">1-A, 2-B, 3-C, 4-D</span></p>"
        },
        {
          "id": 298512,
          "text": "<p><span style=\"font-size:16px;\">1-B, 2-A, 3-D, 4-C</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Match the following hormones to receptors: (INICET NOV 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_yEQI1e3.png\" width=\"872\" height=\"262\"></span></p>",
      "unique_key": "Q9861720",
      "question_audio": null,
      "question_video": null,
      "map_id": 35489177,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. D) 1-B, 2-A, 3-D, 4-C</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\"><strong>(1-B)</strong> Acetylcholine works through ligand-gated channels (like other neurotransmitters such as serotonin and GABA)</span></li><li><span style=\"font-size:16px;\"><strong>(2-A)</strong> Insulin functions via the receptor tyrosine kinase (RTK) pathway, with insulin receptor substrate (IRS) as its substrate</span></li><li><span style=\"font-size:16px;\"><strong>(3-D)</strong> Growth hormone operates through the JAK-STAT pathway (non-receptor tyrosine kinase pathway)</span></li><li><span style=\"font-size:16px;\"><strong>(4-C)</strong> Thyroxine, being lipid-soluble, acts through nuclear receptors</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The distinct receptor mechanisms for different hormone classes:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">Acetylcholine → Ligand-gated channels</span></li><li><span style=\"font-size:16px;\">Insulin → Tyrosine kinase pathway</span></li><li><span style=\"font-size:16px;\">Growth hormone → JAK-STAT pathway</span></li><li><span style=\"font-size:16px;\">Thyroxine → Nuclear receptors</span></li></ul>",
      "correct_choice_id": 298512,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/74903/INI-CET_NOV_2024_Medicine_Q_-_28.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/74903/INI-CET_NOV_2024_Medicine_Q_-_28.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74904,
      "choices": [
        {
          "id": 298513,
          "text": "<p><span style=\"font-size:16px;\">Nevi</span></p>"
        },
        {
          "id": 298514,
          "text": "<p><span style=\"font-size:16px;\">Atrial myxoma</span></p>"
        },
        {
          "id": 298515,
          "text": "<p><span style=\"font-size:16px;\">Myxoid neurofibroma</span></p>"
        },
        {
          "id": 298516,
          "text": "<p><span style=\"font-size:16px;\">Ebstein's anomaly</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Which of the following is not a component of NAME syndrome? (INICET NOV 2024)</span></p>",
      "unique_key": "Q3961729",
      "question_audio": null,
      "question_video": null,
      "map_id": 35489178,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. D) Ebstein's anomaly</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">NAME syndrome is now recognized as part of the Carney complex, which falls under Multiple Endocrine Other Organ Neoplasia (MEON). The NAME acronym stands for:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">N: Nevi (blue nevi – skin manifestation)</span></li><li><span style=\"font-size:16px;\">A: Atrial myxoma</span></li><li><span style=\"font-size:16px;\">M: Myxoid neurofibroma</span></li><li><span style=\"font-size:16px;\">E: Ephelides (freckles)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\">Ebstein's anomaly is not a component of this syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:16px;\">NAME syndrome (now part of Carney complex) consists of Nevi (blue), Atrial myxoma, Myxoid neurofibroma, and Ephelides (freckles). Ebstein's anomaly is not a component of this syndrome.</span></p>",
      "correct_choice_id": 298516,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/74904/INI-CET_NOV_2024_Medicine_Q_-_29.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/74904/INI-CET_NOV_2024_Medicine_Q_-_29.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74905,
      "choices": [
        {
          "id": 298517,
          "text": "<p><span style=\"font-size:16px;\">Making a fist with forearm exercise</span></p>"
        },
        {
          "id": 298518,
          "text": "<p><span style=\"font-size:16px;\">Tourniquet should be tied and released as soon as possible</span></p>"
        },
        {
          "id": 298519,
          "text": "<p><span style=\"font-size:16px;\">Should be collected in sitting position &amp; better to avoid prolonged immobilization</span></p>"
        },
        {
          "id": 298520,
          "text": "<p><span style=\"font-size:16px;\">Sample should be analyzed within 15–30 min of collection</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Which of the following should be prevented when collecting a blood sample for serum calcium? (INICET NOV 2024)</span></p>",
      "unique_key": "Q6989240",
      "question_audio": null,
      "question_video": null,
      "map_id": 35489179,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) Making a fist with forearm exercise</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Making a fist and performing forearm exercises during blood collection for calcium measurement should be prevented, as it can cause muscle ischemia and erroneously increase the calcium value in the sample. This is a practical consideration during blood collection when lab personnel often ask patients to make a fist and perform repetitive movements to better visualize veins.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Tourniquet should be tied and released as soon as possible:&nbsp;</strong>The tourniquet should be tied and released as soon as possible to avoid erroneously high calcium values. In some cases, for repeat calcium or PTH measurements, it's recommended to avoid tourniquet use altogether.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Should be collected in sitting position &amp; better to avoid prolonged immobilization:</strong> Collecting samples in sitting position and avoiding prolonged immobilization is recommended, as standing can increase serum calcium levels. Prolonged sitting/immobilization can also affect values due to bone lysis.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Sample should be analyzed within 15–30 min of collection:</strong> Samples should ideally be analyzed within 15–30 minutes of collection. If delay is anticipated, the sample should be kept on ice (good for 2 hours) or centrifuged to obtain plasma/serum (stable at room temperature for 8 hours).</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Making a fist and performing forearm exercises during blood collection for calcium measurement should be avoided, as it can falsely elevate calcium levels through muscle ischemia.</span></p>",
      "correct_choice_id": 298517,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54304,
      "choices": [
        {
          "id": 216685,
          "text": "<p><span style=\"font-size:12.0pt;\">Elevation</span></p>"
        },
        {
          "id": 216686,
          "text": "<p><span style=\"font-size:12.0pt;\">Adduction</span></p>"
        },
        {
          "id": 216687,
          "text": "<p><span style=\"font-size:12.0pt;\">Abduction</span></p>"
        },
        {
          "id": 216688,
          "text": "<p><span style=\"font-size:12.0pt;\">Ptosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In CN III palsy, which of the following is not affected?</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q2516441",
      "question_audio": null,
      "question_video": null,
      "map_id": 35489180,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Abduction</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Cranial Nerve III (CN III), also known as the oculomotor nerve, innervates several muscles responsible for eye movements and eyelid elevation. These muscles include the superior rectus (elevation), medial rectus (adduction), inferior rectus (depression), and inferior oblique (extorsion and elevation in adduction). It also innervates the levator palpebrae superioris muscle, which is responsible for elevating the eyelid.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Abduction</strong> is controlled by the lateral rectus muscle, which is innervated by the abducens nerve (CN VI), not the oculomotor nerve. Therefore, abduction is not affected in CN III palsy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In CN III palsy, the functions of these muscles are compromised, leading to issues such as:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Elevation</strong>: Elevation is affected due to the involvement of the superior rectus muscle innervated by CN III.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Adduction</strong>: Adduction is affected due to the involvement of the medial rectus muscle innervated by CN III.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Ptosis</strong>: Ptosis occurs due to the involvement of the levator palpebrae superioris muscle innervated by CN III.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In CN III palsy, abduction is not affected because it is controlled by the lateral rectus muscle, which is innervated by the abducens nerve (CN VI).</span></p>",
      "correct_choice_id": 216687,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54304/INI-CET_May_2024Medicine_Question_49.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54304/INI-CET_May_2024Medicine_Question_49.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54305,
      "choices": [
        {
          "id": 216689,
          "text": "<p><span style=\"font-size:12.0pt;\">Dravet Syndrome</span></p>"
        },
        {
          "id": 216690,
          "text": "<p><span style=\"font-size:12.0pt;\">Lennox-Gastaut Syndrome</span></p>"
        },
        {
          "id": 216691,
          "text": "<p><span style=\"font-size:12.0pt;\">Tuberous Sclerosis</span></p>"
        },
        {
          "id": 216692,
          "text": "<p><span style=\"font-size:12.0pt;\">Rett Syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Cannabinoids are approved in all of the following except:</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q9409154",
      "question_audio": null,
      "question_video": null,
      "map_id": 35489181,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Rett Syndrome</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Rett Syndrome</strong>: A rare genetic neurological disorder that primarily affects girls and leads to severe cognitive and physical impairments. While new treatments are being explored, cannabinoids are not currently approved for managing this condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Cannabinoids, specifically cannabidiol (CBD) formulations such as Epidiolex, have been FDA-approved for use in treating certain epileptic syndromes. These include:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Dravet Syndrome</strong>: A severe form of epilepsy that begins in infancy, characterized by prolonged seizures.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Lennox-Gastaut Syndrome</strong>: A childhood-onset epilepsy that involves multiple types of seizures and often results in cognitive impairment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Tuberous Sclerosis</strong>: A genetic disorder that causes benign tumors to form in many parts of the body, including the brain, which can lead to seizures.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Cannabinoids, such as Epidiolex, are approved for the treatment of Dravet Syndrome, Lennox-Gastaut Syndrome, and Tuberous Sclerosis, but not for Rett Syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Note -</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">High-dose Epidiolex is an FDA-approved oil formulation of CBD for use as an add-on treatment for Dravet's and Lennox-Gastaut syndromes and tuberous sclerosis epilepsies. There is clinical evidence for CBD, at lower doses, as an anxiolytic for the treatment of posttraumatic stress, anxiety, and relapse of substance use disorders. Animal studies suggest that this effect of CBD may be mediated by the 5-hydroxytryptamine 1A receptor.</span></p>",
      "correct_choice_id": 216692,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54305/INI-CET_May_2024Medicine_Question_50.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54305/INI-CET_May_2024Medicine_Question_50.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54293,
      "choices": [
        {
          "id": 216641,
          "text": "<p><span style=\"font-size:12.0pt;\">Arthritis</span></p>"
        },
        {
          "id": 216642,
          "text": "<p><span style=\"font-size:12.0pt;\">GI bleeding</span></p>"
        },
        {
          "id": 216643,
          "text": "<p><span style=\"font-size:12.0pt;\">Abdominal pain</span></p>"
        },
        {
          "id": 216644,
          "text": "<p><span style=\"font-size:12.0pt;\">Skin rash</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following in IgA vasculitis warrants the use of corticosteroids?</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q7861595",
      "question_audio": null,
      "question_video": null,
      "map_id": 35489182,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) GI bleeding</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">IgA vasculitis, also known as Henoch-Schönlein purpura, typically presents with symptoms such as arthritis, abdominal pain, and skin rash. These symptoms are often managed with supportive care and nonsteroidal anti-inflammatory drugs (NSAIDs). However, the use of corticosteroids is reserved for more severe manifestations of the disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>GI bleeding</strong>: In cases where IgA vasculitis leads to gastrointestinal bleeding, corticosteroids are warranted. This is because GI bleeding indicates a severe form of the disease involving the gastrointestinal tract, which requires more aggressive treatment to reduce inflammation and prevent further complications.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Arthritis</strong>: Joint pain and swelling associated with IgA vasculitis are usually mild and managed with NSAIDs or supportive care. Corticosteroids are not typically indicated for arthritis alone in this context.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Abdominal pain</strong>: Abdominal pain in IgA vasculitis can often be managed with supportive care and NSAIDs. Corticosteroids are reserved for severe cases or when there is evidence of significant gastrointestinal involvement.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Skin rash</strong>: The characteristic purpuric rash of IgA vasculitis is usually self-limiting and does not require corticosteroids for treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Corticosteroids are indicated in IgA vasculitis primarily for severe manifestations such as gastrointestinal bleeding, indicating more extensive disease involvement.</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">Other manifestations, such as arthritis, abdominal pain, and skin rash, are generally self-limiting and respond well to supportive care. Corticosteroids are not typically required for these symptoms unless they are part of a more severe systemic involvement.</span></p>",
      "correct_choice_id": 216642,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54293/INI-CET_May_2024Medicine_Question_38.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "CriteriaBased",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54293/INI-CET_May_2024Medicine_Question_38.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 48794,
      "choices": [
        {
          "id": 194759,
          "text": "<p>Conjugated Hyperbilirubinemia</p>"
        },
        {
          "id": 194760,
          "text": "<p>Raised Alkaline Phosphatase</p>"
        },
        {
          "id": 194761,
          "text": "<p>Dark or Black liver on histology</p>"
        },
        {
          "id": 194762,
          "text": "<p>Mutation of MRP2 Gene</p>"
        }
      ],
      "text": "<p>Which of the following statements about Dubin-Johnson Syndrome is incorrect?&nbsp;(NEET PG 2015)</p>",
      "unique_key": "Q1306553",
      "question_audio": null,
      "question_video": null,
      "map_id": 35489183,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><strong>Correct Answer: B. Raised Alkaline Phosphatase</strong></p><p>&nbsp;</p><p><strong>Explanation:</strong></p><p>&nbsp;</p><p>Dubin-Johnson syndrome is characterized by <strong>conjugated hyperbilirubinemia but normal alkaline phosphatase levels</strong>. This benign, rare disorder features defective expression of MRP2 (multidrug resistance-associated protein 2), an ATP-dependent canalicular membrane transporter responsible for biliary excretion of bilirubin conjugates. Despite the conjugated hyperbilirubinemia, liver tests other than bilirubin are typically normal in Dubin-Johnson syndrome, including alkaline phosphatase, which distinguishes it from other causes of conjugated hyperbilirubinemia like obstruction.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option A. Conjugated Hyperbilirubinemia</strong>: Dubin-Johnson syndrome presents with predominantly conjugated hyperbilirubinemia, with total bilirubin concentrations typically between 34-85 μmol/L (2-5 mg/dL).</p><p>&nbsp;</p><p><strong>Option C. Dark or Black liver on histology</strong>: A cardinal feature of Dubin-Johnson syndrome is the accumulation of dark, coarsely granular pigment in the lysosomes of centrilobular hepatocytes, resulting in a grossly black appearance of the liver.</p><p>&nbsp;</p><p><strong>Option D. Mutation of MRP2 Gene</strong>: Several different mutations in the MRP2 gene produce the Dubin-Johnson phenotype. MRP2 is undoubtedly important in the biliary excretion of conjugated bilirubin, and its defective expression is the molecular basis of this syndrome.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Dubin-Johnson syndrome is distinguished from other causes of conjugated hyperbilirubinemia by normal liver biochemical tests (including normal alkaline phosphatase), and characteristic black pigmentation of the liver resulting from MRP2 deficiency.</span></p>",
      "correct_choice_id": 194760,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 84304,
      "choices": [
        {
          "id": 335792,
          "text": "<p><span style=\"font-size:12.0pt;\">Polyarteritis Nodosa (PAN)</span></p>"
        },
        {
          "id": 335793,
          "text": "<p><span style=\"font-size:12.0pt;\">Microscopic Polyangiitis</span></p>"
        },
        {
          "id": 335794,
          "text": "<p><span style=\"font-size:12.0pt;\">Giant Cell Vasculitis</span></p>"
        },
        {
          "id": 335795,
          "text": "<p><span style=\"font-size:12.0pt;\">Takayasu's Disease</span></p>"
        }
      ],
      "text": "<p>Which of the following is classified as a 'Small Vessel Vasculitis'? (NEET PG 2016)</p>",
      "unique_key": "Q4531600",
      "question_audio": null,
      "question_video": null,
      "map_id": 35489184,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><strong>Ans. B) Microscopic Polyangiitis</strong></p><p>&nbsp;</p><p>Microscopic polyangiitis is classified as a small vessel vasculitis in the Chapel classification of vasculitis (2012). It primarily affects capillaries, venules, and arterioles, which are the defining vessels involved in small vessel vasculitis. MPA is characterized by pauci-immune necrotizing vasculitis that frequently manifests with glomerulonephritis and pulmonary capillaritis.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option A. Polyarteritis Nodosa (PAN)</strong>: PAN is classified as a medium vessel vasculitis. It predominantly affects medium and small muscular arteries, particularly at vessel bifurcations. Unlike small vessel vasculitides, PAN does not typically involve arterioles, capillaries, or venules.</p><p>&nbsp;</p><p><strong>Option C. Giant Cell Vasculitis</strong>: This is a large vessel vasculitis that primarily affects the aorta and its major branches, particularly the extracranial branches of the carotid artery. Its predilection for temporal arteries has given it the alternative name of temporal arteritis.</p><p>&nbsp;</p><p><strong>Option D. Takayasu's Disease</strong>: Takayasu arteritis is classified as a large vessel vasculitis. It primarily affects the aorta and its branches, with a strong predilection for the aortic arch and its major branches. Subclavian artery involvement is most common (93% of cases).</p><p>&nbsp;</p><p><strong>Educational Objective:</strong></p><p>&nbsp;</p><p>Microscopic polyangiitis is a small vessel vasculitis characterized by necrotizing vasculitis affecting small vessels with few or no immune complexes. It commonly presents with glomerulonephritis and pulmonary capillaritis, and is frequently associated with p-ANCA (anti-MPO) antibodies, distinguishing it from other vessel-specific vasculitides.</p>",
      "correct_choice_id": 335793,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 48260,
      "choices": [
        {
          "id": 192635,
          "text": "<p><span style=\"font-size:12.0pt;\">Polyarteritis nodosa</span></p>"
        },
        {
          "id": 192636,
          "text": "<p><span style=\"font-size:12.0pt;\">Wegener's granulomatosis</span></p>"
        },
        {
          "id": 192637,
          "text": "<p><span style=\"font-size:12.0pt;\">Henoch-Schonlein purpura</span></p>"
        },
        {
          "id": 192638,
          "text": "<p><span style=\"font-size:12.0pt;\">Churg-Strauss syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">C-ANCA positivity is highly specific for?(NEET PG 2017)</span></p>",
      "unique_key": "Q7623282",
      "question_audio": null,
      "question_video": null,
      "map_id": 35489185,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><strong>Ans. B) Wegener's granulomatosis</strong></p><p>&nbsp;</p><p><strong>Explanation:</strong></p><p>&nbsp;</p><p>C-ANCA (cytoplasmic antineutrophil cytoplasmic antibodies) with specificity for proteinase-3 is highly specific for Wegener's granulomatosis, now called granulomatosis with polyangiitis (GPA). More than 90% of patients with typical active granulomatosis with polyangiitis have detectable antibodies to proteinase-3. The specificity of antiproteinase-3 antibodies for Wegener's granulomatosis is very high (&gt;95%), making it a valuable diagnostic marker.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option A. Polyarteritis nodosa</strong>: Polyarteritis nodosa is ANCA-negative. It is a non-granulomatous medium vessel vasculitis without glomerulonephritis or pulmonary involvement, often featuring testicular involvement and microaneurysms visible on angiography.</p><p>&nbsp;</p><p><strong>Option C. Henoch-Schonlein purpura</strong>: HSP (now called IgA vasculitis) is characterized by IgA-mediated vasculitis with immune complex deposition rather than ANCA association. Diagnosis involves skin biopsy with direct immunofluorescence showing leukocytoclastic vasculitis with IgA and C3 deposition in vessel walls.</p><p>&nbsp;</p><p><strong>Option D. Churg-Strauss syndrome</strong>: Now called eosinophilic granulomatosis with polyangiitis (EGPA), this condition is primarily associated with p-ANCA (perinuclear ANCA) with antimyeloperoxidase specificity rather than c-ANCA. Approximately 48% of patients with EGPA have circulating ANCA that is usually antimyeloperoxidase.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong></p><p>&nbsp;</p><p>C-ANCA with anti-proteinase-3 specificity serves as a highly specific serological marker for granulomatosis with polyangiitis (Wegener's), providing an important diagnostic tool that helps differentiate it from other vasculitides that are either ANCA-negative or associated with different ANCA patterns.</p>",
      "correct_choice_id": 192636,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "InvestigationBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11217,
      "choices": [
        {
          "id": 44834,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypokalemia</span></span></span></span></p>"
        },
        {
          "id": 44835,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyponatremia</span></span></span></span></p>"
        },
        {
          "id": 44836,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypocalcemia</span></span></span></span></p>"
        },
        {
          "id": 44837,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypercalcemia</span></span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pseudo P pulmonale is seen in which electrolyte abnormality?</span></span> <span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(NEET PG 2018)</span></span></p>",
      "unique_key": "Q4361551",
      "question_audio": null,
      "question_video": null,
      "map_id": 35489186,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. Hypokalemia</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pseudo P pulmonale, characterized by exaggerated amplitude in the P wave, can be observed on an ECG in the context of hypokalemia. This electrolyte disturbance affects cardiac electrophysiology, leading to various changes including prolonged QT interval, presence of U waves, T wave flattening or inversion, and sometimes pseudo-infarction patterns, which can mimic myocardial infarction.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypokalemia can result in these distinct ECG changes due to its influence on cellular membrane potentials in cardiac cells, which alters the normal propagation of electrical impulses through the myocardium.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Hyponatremia:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Does not typically cause prominent P wave changes; its ECG manifestations are less specific and often involve general effects on conduction and contractility. </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Note - Hyponatremia is usually silent on the ECG</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Hypocalcemia:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Associated with prolonged QT interval due to an elongation of the ST segment but not with pseudo P pulmonale.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Hypercalcemia:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Typically presents with a shortened QT interval and shortened ST segment, differing significantly from the changes seen in hypokalemia.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/22/screenshot-2024-07-22-164018.jpg\" style=\"height:591px; width:1000px\" /></span></span></strong></p>",
      "correct_choice_id": 44834,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 84349,
      "choices": [
        {
          "id": 335968,
          "text": "<p>Hepatitis A</p>"
        },
        {
          "id": 335969,
          "text": "<p>Hepatitis B</p>"
        },
        {
          "id": 335970,
          "text": "<p>Hepatitis C</p>"
        },
        {
          "id": 335971,
          "text": "<p>Hepatitis E</p>"
        }
      ],
      "text": "<p>Prophylaxis is available for all of the following, except:&nbsp;(NEET PG 2015)</p>",
      "unique_key": "Q4489378",
      "question_audio": null,
      "question_video": null,
      "map_id": 35489187,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><strong>Correct Answer: C. Hepatitis C</strong></p><p>&nbsp;</p><p><strong>Explanation:</strong></p><p>&nbsp;</p><p>No effective prophylaxis is currently available for hepatitis C. Unlike hepatitis A, B, and E, there is no vaccine or immunoglobulin preparation that can provide passive or active immunization against HCV infection. The primary preventive strategies for hepatitis C focus on screening blood products, avoiding needle sharing, and implementing universal precautions in healthcare settings. Post-exposure prophylaxis with antiviral agents has not been established as effective for preventing HCV infection after exposure.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option A. Hepatitis A:</strong> Prophylaxis for hepatitis A is available through both active and passive immunization. Active immunization involves formalin-inactivated vaccines (Havrix and Vaqta), while passive immunization uses immune globulin (IG). Hepatitis A vaccination provides long-lasting protection, and IG can be effective when administered before exposure or early in the incubation period.</p><p>&nbsp;</p><p><strong>Option B. Hepatitis B:&nbsp;</strong>Both active and passive prophylaxis are available for hepatitis B. Active immunization uses recombinant vaccines containing HBsAg (Recombivax-HB and Engerix-B). Passive immunization with hepatitis B immunoglobulin (HBIG) is used for post-exposure prophylaxis. The combination of HBIG and vaccine is recommended for certain high-risk exposures.</p><p>&nbsp;</p><p><strong>Option D. Hepatitis E:&nbsp;</strong>Safe and effective recombinant vaccines for hepatitis E have been developed and are available in endemic areas. The Chinese hepatitis E vaccine has demonstrated long-lasting protection in clinical trials, documented for up to 4.5 years. While not widely available in the United States, prophylaxis for hepatitis E does exist.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong></p><p>&nbsp;</p><p>Hepatitis C stands alone among the major hepatitis viruses as having no established prophylactic vaccine or immunoglobulin preparation, making prevention dependent on avoiding exposure.</p>",
      "correct_choice_id": 335970,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 84306,
      "choices": [
        {
          "id": 335800,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyperviscosity</span></p>"
        },
        {
          "id": 335801,
          "text": "<p><span style=\"font-size:12.0pt;\">Monoclonal IgM paraprotein</span></p>"
        },
        {
          "id": 335802,
          "text": "<p><span style=\"font-size:12.0pt;\">Normal complement levels</span></p>"
        },
        {
          "id": 335803,
          "text": "<p><span style=\"font-size:12.0pt;\">Strongly Positive Rheumatoid factor</span></p>"
        }
      ],
      "text": "<p>Which of the following is not typically associated with Type I Cryoglobulinemia? (NEET PG 2016)</p>",
      "unique_key": "Q3273161",
      "question_audio": null,
      "question_video": null,
      "map_id": 35489188,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><strong>Ans. D) Strongly Positive Rheumatoid factor</strong></p><p>&nbsp;</p><p>Type I cryoglobulinemia is characterized by the presence of monoclonal immunoglobulins (usually IgM or IgG) that precipitate in cold temperatures. Type I cryoglobulinemia features include monoclonal Ig (usually IgM), hyperviscosity, thrombosis, and normal complement levels. Unlike Types II and III (mixed cryoglobulinemias), Type I cryoglobulinemia is not associated with rheumatoid factor activity.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option A. Hyperviscosity</strong>: This is incorrect as an answer because hyperviscosity is a key feature of Type I cryoglobulinemia. The monoclonal paraproteins in Type I can lead to symptoms of hyperviscosity, including visual disturbances, headaches, and neurological symptoms.</p><p>&nbsp;</p><p><strong>Option B. Monoclonal IgM paraprotein</strong>: This is incorrect as an answer because monoclonal immunoglobulins, particularly IgM, are the defining characteristic of Type I cryoglobulinemia, typically associated with plasma cell dyscrasias.</p><p>&nbsp;</p><p><strong>Option C. Normal complement levels</strong>: This is incorrect as an answer because Type I cryoglobulinemia is indeed associated with normal C3/C4 complement levels, unlike the hypocomplementemia seen in Type II mixed cryoglobulinemia.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong>&nbsp;</p><p>&nbsp;</p><p>Type I cryoglobulinemia is characterized by monoclonal immunoglobulins, hyperviscosity, and normal complement levels, but lacks the rheumatoid factor activity that is characteristic of mixed cryoglobulinemias (Types II and III).</p>",
      "correct_choice_id": 335803,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 48428,
      "choices": [
        {
          "id": 193303,
          "text": "<p><span style=\"font-size:12.0pt;\">Low blood pressure</span></p>"
        },
        {
          "id": 193304,
          "text": "<p><span style=\"font-size:12.0pt;\">Decrease in extracellular fluid (ECF)</span></p>"
        },
        {
          "id": 193305,
          "text": "<p><span style=\"font-size:12.0pt;\">Decreased sodium to potassium ratio</span></p>"
        },
        {
          "id": 193306,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased protein breakdown</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Primary adrenal insufficiency causes all of the following, except? (NEET PG 2017)</span></p>",
      "unique_key": "Q7520740",
      "question_audio": null,
      "question_video": null,
      "map_id": 35489189,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><strong>Ans. D) Increased protein breakdown</strong></p><p>&nbsp;</p><p><strong>Explanation:</strong></p><p>&nbsp;</p><p>Primary adrenal insufficiency (Addison's disease) involves impaired production of glucocorticoids, mineralocorticoids, and adrenal androgen precursors. While glucocorticoid deficiency can affect protein metabolism, it actually leads to decreased protein breakdown (catabolism), not increased. Glucocorticoids normally promote protein catabolism, so in their absence, protein breakdown is reduced rather than increased.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option A. Low blood pressure</strong>: This is a classic feature of primary adrenal insufficiency. Mineralocorticoid deficiency causes sodium wasting and volume depletion, resulting in hypotension and often postural hypotension, which can be profound in adrenal crisis.</p><p>&nbsp;</p><p><strong>Option B. Decrease in extracellular fluid (ECF)</strong>: This is correct for primary adrenal insufficiency. Aldosterone deficiency leads to sodium loss and water excretion, reducing ECF volume. This contributes to the hypotension seen in Addison's disease and is part of the clinical presentation.</p><p>&nbsp;</p><p><strong>Option C. Decreased sodium to potassium ratio</strong>: This is accurate for primary adrenal insufficiency. Mineralocorticoid deficiency leads to increased potassium retention and sodium wasting, resulting in a decreased Na:K ratio. Hyponatremia and hyperkalemia are common laboratory findings.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong>&nbsp;</p><p>&nbsp;</p><p>Primary adrenal insufficiency (Addison's disease) is characterized by decreased protein catabolism (not increased), hypotension, decreased ECF volume, and a decreased sodium to potassium ratio due to deficiency of glucocorticoids and mineralocorticoids.</p>",
      "correct_choice_id": 193306,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11218,
      "choices": [
        {
          "id": 44838,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">FEV1/FVC &lt;0.7 and FEV1 &lt; 30%</span></span></span></span></p>"
        },
        {
          "id": 44839,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">FEV1/FVC &lt;0.7 and FEV1 &lt;70%</span></span></span></span></p>"
        },
        {
          "id": 44840,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">FEV1/FVC&lt;0.7 and FEV1&lt; 50%</span></span></span></span></p>"
        },
        {
          "id": 44841,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Both A and C</span></span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The Gold&#39;s criteria for very severe COPD is:</span></span> <span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(NEET PG 2018)</span></span></p>",
      "unique_key": "Q4486056",
      "question_audio": null,
      "question_video": null,
      "map_id": 35489190,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) FEV1/FVC &lt;0.7 and FEV1 &lt; 30%</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">According to the GOLD (Global Initiative for Chronic Obstructive Lung Disease) criteria for staging chronic obstructive pulmonary disease (COPD), very severe COPD is classified as Stage IV. This stage is defined by a FEV1/FVC ratio (forced expiratory volume in one second/forced vital capacity) less than 0.7, which indicates the presence of airflow limitation, and a FEV1 less than 30% of the predicted value. This level of FEV1 signifies a very severe reduction in lung function and typically corresponds with significant symptoms and health status impairment.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><u><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></strong></span></span></u></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/22/screenshot-2024-07-22-164040.jpg\" style=\"height:335px; width:992px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Note:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Currently Class C+D have been combined and called Class E</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Classification of types have been updated.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><em><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reference: GOLD 2023 guidelines</span></span></em></strong></p>",
      "correct_choice_id": 44838,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 84350,
      "choices": [
        {
          "id": 335972,
          "text": "<p>Pagophagia</p>"
        },
        {
          "id": 335973,
          "text": "<p>Koilonychia</p>"
        },
        {
          "id": 335974,
          "text": "<p>Blue Sclera</p>"
        },
        {
          "id": 335975,
          "text": "<p>Macroglossia</p>"
        }
      ],
      "text": "<p>Which of the following signs and symptoms is not highly specific for iron deficiency?&nbsp;(NEET PG 2015)</p>",
      "unique_key": "Q1336065",
      "question_audio": null,
      "question_video": null,
      "map_id": 35489191,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><strong>Correct Answer: D. Macroglossia</strong></p><p>&nbsp;</p><p><strong>Explanation:</strong></p><p>&nbsp;</p><p>Macroglossia (abnormally enlarged tongue) is not a specific finding in iron deficiency anemia. It occurs instead in conditions like amyloidosis, hypothyroidism, and certain genetic disorders such as Down syndrome.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option A. Pagophagia (ice eating):&nbsp;</strong>This specific form of pica is highly characteristic of iron deficiency. The craving and consumption of ice is a well-recognized manifestation that strongly suggests iron deficiency when present.</p><p>&nbsp;</p><p><strong>Option B. Koilonychia (\"spoon nails\"):</strong> These thin, concave nails with raised edges develop gradually in chronic iron deficiency anemia and serve as a helpful diagnostic sign when present.</p><p>&nbsp;</p><p><strong>Option C. Blue Sclera:&nbsp;</strong>The bluish discoloration of the sclera occurs in advanced iron deficiency due to thinning of collagen, which allows the underlying choroidal veins to become visible. This finding strongly points to significant iron deficiency.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong></p><p>&nbsp;</p><p>Pagophagia, koilonychia, and blue sclera are recognized clinical manifestations of iron deficiency anemia, while macroglossia is not part of this clinical picture and suggests alternative diagnoses.</p>",
      "correct_choice_id": 335975,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 84307,
      "choices": [
        {
          "id": 335804,
          "text": "<p><span style=\"font-size:12.0pt;\">More common in males</span></p>"
        },
        {
          "id": 335805,
          "text": "<p><span style=\"font-size:12.0pt;\">Sleep EEG studies have shown disruption in REM sleep</span></p>"
        },
        {
          "id": 335806,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased cortisol response to stress</span></p>"
        },
        {
          "id": 335807,
          "text": "<p><span style=\"font-size:12.0pt;\">SPECT studies have shown reduced blood flow to the thalamus</span></p>"
        }
      ],
      "text": "<p>Which of the following statements about Fibromyalgia is accurate? (NEET PG 2016)</p>",
      "unique_key": "Q7370710",
      "question_audio": null,
      "question_video": null,
      "map_id": 35489192,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><strong>Ans. B) Sleep EEG studies have shown disruption in REM sleep</strong></p><p>&nbsp;</p><p>Fibromyalgia (FM) is characterized by chronic widespread musculoskeletal pain and tenderness with associated neuropsychological symptoms including fatigue, unrefreshing sleep, cognitive dysfunction, anxiety, and depression. Sleep disturbance is one of the key neuropsychological symptoms reported by FM patients. Sleep EEG studies in fibromyalgia patients consistently demonstrate interruption of deep sleep patterns by intrusion of alpha waves, which leads to disruption in REM sleep. This sleep architecture disturbance contributes to the unrefreshing sleep and persistent fatigue reported by patients.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option A. More common in males</strong>: This is incorrect. Fibromyalgia is far more common in women than in men, with a ratio of ~9:1 in clinical settings. Even in population-based surveys, the female-to-male ratio is 2-3:1. The epidemiological data clearly demonstrates a strong female predominance in this condition.</p><p>&nbsp;</p><p><strong>Option C. Increased cortisol response to stress</strong>: This is incorrect. Fibromyalgia is not associated with increased cortisol response to stress. In fact, fibromyalgia is often associated with dysregulation of the hypothalamic-pituitary-adrenal axis, but this typically manifests as a blunted cortisol response rather than an increased response.</p><p>&nbsp;</p><p><strong>Option D. SPECT studies have shown reduced blood flow to the thalamus</strong>: This is incorrect. While central nervous system involvement is key in fibromyalgia pathophysiology, there is no established evidence showing SPECT studies with reduced blood flow to the thalamus as a consistent finding in this condition.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong></p><p>&nbsp;</p><p>Sleep disturbance is a core feature of fibromyalgia, with objective EEG abnormalities showing alpha wave intrusion into deeper sleep stages and REM disruption, contributing to the unrefreshing sleep and persistent fatigue that characterize this condition.</p>",
      "correct_choice_id": 335805,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 48434,
      "choices": [
        {
          "id": 193327,
          "text": "<p><span style=\"font-size:12.0pt;\">It is a premalignant condition</span></p>"
        },
        {
          "id": 193328,
          "text": "<p><span style=\"font-size:12.0pt;\">Usually increased acid secretion</span></p>"
        },
        {
          "id": 193329,
          "text": "<p><span style=\"font-size:12.0pt;\">May be confused with Zollinger-Ellison Syndrome</span></p>"
        },
        {
          "id": 193330,
          "text": "<p><span style=\"font-size:12.0pt;\">Associated with protein-losing enteropathy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following statements about Menetrier’s disease are true, except: (NEET PG 2017)</span></p>",
      "unique_key": "Q8460662",
      "question_audio": null,
      "question_video": null,
      "map_id": 35489193,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><strong>Ans. B) Usually increased acid secretion</strong></p><p>&nbsp;</p><p><strong>Explanation:</strong></p><p>&nbsp;</p><p>Ménétrier's disease is characterized by decreased gastric acid secretion, not increased secretion. The disease features massive foveolar hyperplasia with marked reduction in oxyntic glands and parietal cells, which are responsible for acid production. Histologically, there is hyperplasia of surface and glandular mucous cells with a marked reduction in oxyntic glands, parietal cells, and chief cells.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option</strong> <strong>A. It is a premalignant condition:</strong> Ménétrier's disease is considered premalignant by some clinicians, though the exact risk of neoplastic progression is not well defined.</p><p>&nbsp;</p><p><strong>Option C. May be confused with Zollinger:</strong> Ellison Syndrome - Both conditions can present with similar symptoms including abdominal pain, though ZES has increased acid secretion while Ménétrier's has decreased acid secretion.</p><p>&nbsp;</p><p><strong>Option</strong> <strong>D. Associated with protein:</strong> losing enteropathy - Twenty to 100% of patients with Ménétrier's disease develop a protein-losing gastropathy due to hypersecretion of gastric mucus, accompanied by hypoalbuminemia and edema.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong></p><p>&nbsp;</p><p>&nbsp;Ménétrier's disease is characterized by hypochlorhydria (decreased acid secretion) due to parietal cell loss, which distinguishes it from hypersecretory conditions like Zollinger-Ellison syndrome despite potential overlap in clinical presentation.</p>",
      "correct_choice_id": 193328,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11219,
      "choices": [
        {
          "id": 44842,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bartter syndrome</span></span></span></span></p>"
        },
        {
          "id": 44843,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gitelman&#39;s syndrome</span></span></span></span></p>"
        },
        {
          "id": 44844,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Liddle&#39;s syndrome</span></span></span></span></p>"
        },
        {
          "id": 44845,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fanconi&#39;s syndrome</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 35-year-old female patient has hypokalemia, hypertension and metabolic alkalosis. What is the most likely etiology?</span></span> <span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(NEET PG 2018)</span></span></p>",
      "unique_key": "Q5560066",
      "question_audio": null,
      "question_video": null,
      "map_id": 35489194,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Liddle&rsquo;s Syndrome</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Liddle&#39;s syndrome is a genetic disorder characterized by early-onset hypertension, hypokalemia, and metabolic alkalosis due to a gain-of-function mutation in the epithelial sodium channel (ENaC). This mutation leads to increased sodium reabsorption in the distal nephron, which indirectly causes potassium loss and elevated blood pressure. The syndrome mimics hyperaldosteronism but occurs in the absence of elevated aldosterone levels.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/23/nm16.jpg\" style=\"height:467px; width:700px\" /></span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypokalemia + HTN causes:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aldosterone Activation</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Liddle syndrome&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(ENaC channel Gain of function mutation)</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Apparent Mineralocorticoid Excess&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(AME) (11Beta-HSD loss of function)</span></span></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&darr;11-&beta;HSD&rarr;&uarr;Cortisol &rarr;&uarr;Stimulation of MR receptor &rarr; HTN + Hypokalemia + alkalosis</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Geller Syndrome&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Mineralocorticoid mutation responding to progesterone): Presents in pregnancy. Rx with specific drug like&nbsp;<em><strong>Finerenone</strong>.</em></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucocorticoid remediable Hyperaldosteronism&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(GRA): Chimeric gene b/w CYP11B1, B2 causing <strong>ACTH driven hyperaldosteronism.</strong></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Primary Hyperaldosteronism</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A :&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bartter syndrome <strong>mimics <em>loop diuretics</em></strong> which occur due to <strong>loss of function of Na<sup>+</sup>-K<sup>+</sup>-2Cl<sup>-</sup> transporter</strong> at the Loop of Henle. Often patient has <em>NORMOTENSION.</em></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C :&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gitelman syndrome&nbsp;<strong>mimics <em>thiazide diuretic</em></strong> occurring due to <strong>loss of function mutation of Na<sup>+</sup>-Cl<sup>-</sup> transporter in DCT.&nbsp;</strong>Both Bartter and Gitelman syndrome are normotensive</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D :&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gordon syndrome is opposite of Gitelman syndrome characterized by <strong>Gain of function mutation to Na<sup>+</sup>-Cl<sup>-</sup> channel</strong> which occurs either due to GOF of WNT1 pathway (OR) LOF of WNT 4 pathway, leads to <strong>inhibition of ROMK channel causing <em>HYPERKALEMIA.</em></strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Note: Gordon = </span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HTN + Hyperkalemia</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Liddle&#39;s syndrome is characterized by hypertension, hypokalemia, and metabolic alkalosis due to increased activity of sodium channels in the distal nephron, not due to increased aldosterone, distinguishing it from other similar electrolyte disorders.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reference - Harrison 21E/ Physiology of Kidney/Chap 309 - Table 309-1</span></span></strong></p>",
      "correct_choice_id": 44844,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 52314,
      "choices": [
        {
          "id": 208753,
          "text": "<p><span style=\"font-size:12.0pt;\">CPR &amp; Calcium gluconate</span></p>"
        },
        {
          "id": 208754,
          "text": "<p><span style=\"font-size:12.0pt;\">CPR &amp; 20% IV Intralipid</span></p>"
        },
        {
          "id": 208755,
          "text": "<p><span style=\"font-size:12.0pt;\">CPR &amp; Start Dobutamine infusion</span></p>"
        },
        {
          "id": 208756,
          "text": "<p><span style=\"font-size:12.0pt;\">CPR &amp; Start NaHCO3 infusion</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 20-year-old male came to the emergency after sustaining an injury and was given 0.25% bupivacaine for regional anesthesia. A few minutes later, he became unresponsive and pulseless. What would be the ideal management?</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">(NEET PG 2021)</span></p>",
      "unique_key": "Q3336739",
      "question_audio": null,
      "question_video": null,
      "map_id": 35489195,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. CPR &amp; 20% IV Intralipid</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The scenario describes a case of local anesthetic systemic toxicity (LAST), which can occur after the administration of local anesthetics like bupivacaine. LAST can cause severe cardiovascular and central nervous system toxicity, leading to symptoms such as seizures, coma, and cardiovascular collapse, as seen in this patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The management of LAST involves:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Immediate initiation of cardiopulmonary resuscitation (CPR) if the patient is unresponsive and pulseless.</span></li><li><span style=\"font-size:12.0pt;\">Administration of 20% intravenous lipid emulsion (Intralipid). This treatment, known as lipid rescue or lipid emulsion therapy, acts by creating a \"lipid sink\" that absorbs the local anesthetic from the tissues and blood, reducing its toxic effects on the heart and brain.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. CPR &amp; Calcium gluconate:</strong> Calcium gluconate is not the primary treatment for local anesthetic toxicity. It is used in cases of hyperkalemia or calcium channel blocker overdose.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. CPR &amp; Start Dobutamine infusion:</strong> While dobutamine can support cardiac function, it is not specific for treating local anesthetic toxicity and does not address the underlying cause.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. CPR &amp; Start NaHCO3 infusion:</strong> Sodium bicarbonate is used to treat metabolic acidosis and certain poisonings, such as tricyclic antidepressant overdose, but it is not specific for local anesthetic toxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For local anesthetic systemic toxicity (LAST), immediate management includes starting CPR and administering 20% intravenous lipid emulsion (Intralipid) therapy. This approach helps to rapidly reduce the toxic effects of the local anesthetic on the cardiovascular and central nervous systems.</span></p>",
      "correct_choice_id": 208754,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11359,
      "choices": [
        {
          "id": 45402,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Absent p wave</span></span></span></p>"
        },
        {
          "id": 45403,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Absent a wave</span></span></span></p>"
        },
        {
          "id": 45404,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Cannon a wave</span></span></span></p>"
        },
        {
          "id": 45405,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Raised JVP with normal waveform</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A patient presents to you with an irregularly irregular pulse of 120/minute and a pulse deficit of 20. Which of the following would be the JVP finding? (Neet pg 2022)</span></span></span></p>",
      "unique_key": "Q3194721",
      "question_audio": null,
      "question_video": null,
      "map_id": 35489196,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">B. Absent a wave</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient presents with an irregularly irregular pulse, which is highly suggestive of atrial fibrillation (AF). Atrial fibrillation is characterized by the absence of coordinated atrial contractions, leading to an irregularly irregular ventricular response. This irregularity can be confirmed by a pulse deficit, where the heart rate (as measured by auscultation) is higher than the pulse rate (as felt at the periphery).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In atrial fibrillation, the chaotic atrial activity results in the absence of effective atrial contraction. This leads to the absence of a wave in the jugular venous pulse (JVP), as a wave is generated by atrial contraction.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">A. Absent p wave:&nbsp;</span></strong><span style=\"font-size:12.0pt\">While it is true that atrial fibrillation is characterized by the absence of P waves on the ECG, the question specifically asks about the JVP finding, not the ECG finding.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Cannon a wave</span></strong><strong><span style=\"font-size:12.0pt\">:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Cannon a waves are typically seen in conditions where there is atrioventricular dissociation, such as complete heart block. They are not associated with atrial fibrillation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">D. Raised JVP with normal waveform:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Raised JVP can occur in various conditions, but the presence of a normal waveform would not be consistent with atrial fibrillation, where the a wave is absent.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In atrial fibrillation, the jugular venous pulse (JVP) typically shows an absent a wave due to the lack of coordinated atrial contraction.</span></span></p>",
      "correct_choice_id": 45403,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59464,
      "choices": [
        {
          "id": 237169,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Serum Iron studies</span></span></span></p>"
        },
        {
          "id": 237170,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Direct Coomb&rsquo;s test</span></span></span></p>"
        },
        {
          "id": 237171,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Osmotic fragility test</span></span></span></p>"
        },
        {
          "id": 237172,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hb electrophoresis</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A child presents with Hb 6.3 with a history of repeated blood transfusions. Investigations show MCV- 70 fl and the peripheral smear showed a hypochromic microcytic picture. Which of the following investigations should be done next in this child? (FMGE DEC 2021)</span></span></p>",
      "unique_key": "Q6810066",
      "question_audio": null,
      "question_video": null,
      "map_id": 35489197,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Hb electrophoresis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The clinical picture of hypochromic microcytic anemia and the need for repeated blood transfusions suggest a hemoglobinopathy such as thalassemia. Hemoglobin electrophoresis is the definitive test for diagnosing hemoglobinopathies by identifying abnormal hemoglobin variants.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Without the history of blood transfusions, the initial approach would be to conduct serum iron studies to rule out iron deficiency anemia. However, the presence of repeated blood transfusions in this scenario points towards a possible diagnosis of thalassemia, as frequent transfusions can mask iron deficiency and lead to iron overload, making hemoglobin electrophoresis crucial for confirming thalassemia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Serum Iron studies:</span></strong><span style=\"font-size:12.0pt\"> Useful for diagnosing iron deficiency anemia but not for hemoglobinopathies.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Direct Coombs test:</span></strong><span style=\"font-size:12.0pt\"> Used for diagnosing autoimmune hemolytic anemia, not relevant here.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Osmotic fragility test:</span></strong><span style=\"font-size:12.0pt\"> Used for diagnosing hereditary spherocytosis, not suggested by the clinical picture.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hb electrophoresis is essential for diagnosing hemoglobinopathies like thalassemia in a child with a hypochromic microcytic anemia and history of repeated transfusions.</span></span></span></p>",
      "correct_choice_id": 237172,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "FMGE",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59288,
      "choices": [
        {
          "id": 236465,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type 1 hypersensitivity reaction</span></span></p>"
        },
        {
          "id": 236466,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type 2 hypersensitivity reaction</span></span></p>"
        },
        {
          "id": 236467,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type 3 hypersensitivity reaction</span></span></p>"
        },
        {
          "id": 236468,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type 4 hypersensitivity reaction</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Which of the following type of hypersensitivity reactions is seen in Myasthenia gravis? (FMGE JUNE 2022)</span></span></span></p>",
      "unique_key": "Q9968799",
      "question_audio": null,
      "question_video": null,
      "map_id": 35489198,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>B) Type 2 hypersensitivity reaction</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Myasthenia gravis is an autoimmune disorder where antibodies (mainly against the acetylcholine receptor) mediate the disease process. This is classified as a type 2 hypersensitivity reaction, where antibodies target cell surface antigens.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Important Antibodies in Myasthenia Gravis: Acetylcholine Receptor Antibodies (MC), anti-Musk antibodies and anti-LRP4 Antibodies</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Type 1 hypersensitivity reaction:</span></strong><span style=\"font-size:12.0pt\"> IgE-mediated allergic reactions like bronchial asthma</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Type 3 hypersensitivity reaction:</span></strong><span style=\"font-size:12.0pt\"> Immune complex-mediated, e.g., systemic lupus erythematosus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Type 4 hypersensitivity reaction:</span></strong><span style=\"font-size:12.0pt\"> T-cell mediated, e.g., contact dermatitis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Myasthenia gravis is mediated by antibodies and classified as a type 2 hypersensitivity reaction.</span></span></span></p>",
      "correct_choice_id": 236466,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}